No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Daratumumab, Lenalidomide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Cytogenetic Subgroup Analysis from POLLUX

byKathleen Lau

December 10, 2020

in StudyGraphics

#VisualAbstract: Increased incidence of sebaceous carcinomas among solid organ transplant recipients

RelatedReports

Severity of emphysema on pulmonary CT may predict lung cancer location

Chronic Disease

Age-Based Screening for Lung Cancer Surveillance in the US

November 26, 2025

Cardiology

Risk of cardiovascular mortality in patients with gastric cancer

November 10, 2025

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Chronic Disease

2 Minute Medicine: Pharma Roundup – Breakthrough ALS gene therapy, new adult pneumonia vaccine, needle-free obesity treatment, and Pfizer’s business overhaul [October 28, 2025]

October 29, 2025

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

The Scan by 2 Minute Medicine®

World Health Organization warns that one in six infections now antibiotic resistant

October 23, 2025

Oxygenated hypothermic perfusion reduces post-kidney transplant complications

Quick Take: Diffusion-weighted Imaging of Invasive Breast Cancer: Relationship to Distant Metastasis–free Survival

Pembrolizumab plus chemotherapy improves survival in patients with metastatic triple-negative breast cancer

$#VisualAbstract CONTRALTO Phase II: Venetoclax-Rituximab With or Without Bendamustine VS Bendamustine-Rituximab in Relapsed/Refractory Follicular Lymphoma$

#VisualAbstract CONTRALTO Phase II: Venetoclax-Rituximab With or Without Bendamustine VS Bendamustine-Rituximab in Relapsed/Refractory Follicular Lymphoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports